TASER International (Nasdaq: TASR) reported earnings on Aug. 9. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), TASER International beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue improved significantly and GAAP earnings per share expanded.

Margins improved across the board.

Revenue details
 TASER International reported revenue of $28.2 million. The four analysts polled by S&P Capital IQ expected sales of $23.8 million on the same basis. GAAP reported sales were 33% higher than the prior-year quarter's $21.2 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.06. The four earnings estimates compiled by S&P Capital IQ predicted $0.02 per share. GAAP EPS were $0.06 for Q2 versus -$0.04 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 58.5%, 80 basis points better than the prior-year quarter. Operating margin was 21.5%, 1,970 basis points better than the prior-year quarter. Net margin was 12.2%, 2,300 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $26.0 million. On the bottom line, the average EPS estimate is $0.05.

Next year's average estimate for revenue is $107.5 million. The average EPS estimate is $0.22.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 1,007 members out of 1,092 rating the stock outperform, and 85 members rating it underperform. Among 198 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 172 give TASER International a green thumbs-up, and 26 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on TASER International is outperform, with an average price target of $5.67.